Connect with us
European Gaming Congress 2024

Artificial Intelligence

Lateral Flow Assay Market Size to Worth Around USD 16.74 BN by 2032

Published

on

Ottawa, June 13, 2023 (GLOBE NEWSWIRE) — According to Precedence Research, the global lateral flow assay market size is estimated to hit around USD 15.48 billion by 2030. Lateral flow assays work by detecting the presence or absence of a specific target analyte, such as a biomarker or antigen, in a patient’s sample (e.g., blood, urine, saliva). Lateral flow assays are rapid, easy to use, and do not require specialized equipment or technical expertise. They are used for a variety of applications, including pregnancy testing, infectious disease diagnosis, drug screening, and environmental monitoring. However, they may not be as sensitive or specific as other diagnostic methods and may produce false positives or false negatives in certain situations.

Ask here for report sample pages@ https://www.precedenceresearch.com/sample/2883

There are many lab-based apps available that are enabled by the reading apparatus, but they do not require high-tech or expensive equipment. In human health, lateral flow studies are frequently employed. They are employed in residential, point-of-care, and laboratory checking for medical diagnostics. The most popular and well-known uses of lateral flow measurements are home pregnancy checks. However, lateral flow test tools are also used to detect contamination in water, animal feed, and other sources as well as animal illnesses in animals.

Sandwich assays and competing assays are the two categories under which lateral flow studies are categorized. A colored line at the test line position indicates a good sandwich assay. A colored line at the test line position is shown to be absent in a good competitive analysis. One or more test lines can be used to make sandwich and competing tests. For instance, the multiplexed sandwich assay PCRD for nucleic acid lateral flow ELISA has two test lines and one control line. In lateral flow experiments inside the conjugate cushion, nanoparticles of conjugated gold, carbon, or dyed latex are used. Other marking choices include magnetic beads and colored polystyrene beads.

Readers and lateral flow test kits are two different varieties of lateral flow assays. The scanners measure the data, whereas the kits provide a qualitative analysis that shows the existence or lack of sickness. Tabletop and portable lateral flow test devices are the two different models. These battery-operated, compact, low-cost devices have few attachment requirements but offer patients and lab staff a great deal of freedom. A dipstick, lancets, a cartridge, and test sheets for pathogen identification are included in lateral flow assay packages. The sample is placed on the testing apparatus, and the results can be seen as a hue change brought on by conjugate formation.

Advertisement
Stake.com

Report highlights

  • In 2022, the flexibility of lateral flow kits to capture and identify analytes without spraying captured antibodies on test strips resulted in the kits and reagents sector holding a larger revenue share.
  • The clinical testing sector accounted for the biggest portion (77%) due to the increased prevalence of infectious diseases. The simplicity, accessibility, and precision of sandwich tests are expected to lead to the highest revenue share, with the added benefit of not requiring qualified personnel, making them ideal for healthcare environments with limited resources.
  • The sector that sold lateral flow immunoassays had the highest revenue share in 2022.
  • The pharmaceutical and biotechnology firms’ sector is projected to experience the fastest Compound Annual Growth Rate (CAGR) during the forecast period due to strategic efforts such as mergers and acquisitions, product research, product approvals and launches, and the expansion of global operations.
  • North America had the highest income percentage (37%) in 2022, and the COVID-19 pandemic, which increased access to various diagnostic tests and raised public awareness, is expected to drive significant development.

You can further customize the report@ https://www.precedenceresearch.com/customization/2883

Scope of this report

Coverage Details
Market Size in 2030 USD 15.48 Billion
CAGR 3.97% from 2023 to 2032
North America Revenue Share 37% in 2022
Europe Revenue Share 29% in 2022
APAC Revenue Share 25% in 2022
Key Players Abbott Laboratories, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc., Quidel Corporation, Hologic, Inc., PerkinElmer, Inc., Merck KGaA, BD, Siemens Healthineers, bioMérieux SA, Danaher Corporation, QIAGEN N.V., and Others

Regional Snapshots

Due to an increase in the prevalence of various infectious and chronic illnesses, such as Lyme disease and TB, as well as an elevated fatality rate linked to HIV/AIDS in the area, North America is anticipated to lead the global market for lateral flow assays throughout the projection period. Due to a big patient population and cost with rising discretionary income, the United States is expected to retain the highest market share in North America.

With the COVID-19 pandemic, there has been a shift towards home-based testing, and lateral flow assays are well-suited for this application due to their ease of use and rapid turnaround time. Additionally, the market in the region is anticipated to grow, supporting its outstanding portion of the global market income over the course of the projection period. These factors include the number of diagnostic centers, the increased adoption rate of sophisticated infrastructure, and the rise in consumer consciousness. Furthermore, the growing focus on R&D to adopt novel diagnostic solutions is ultimately bolstering the growth of this market across North America. For instance, the American Chemical Society published a research article on ultrasensitive and highly specific lateral flow assay for point-of-care diagnosis, in February 2021.

Advertisement
Stake.com

Abbott Laboratories increased the output of coronavirus test kits in 2020, adding a novel device that might allow for widespread COVID-19 screening. The business has revealed that it is creating a “lateral flow” blood test, which could be used to test the entire populace in large numbers. This development is anticipated to have a favorable effect on the market in the area.

Market dynamics

Drivers

Several key factors are driving the growth of the global lateral flow assay market, including the widespread occurrence of infectious diseases, an increasing elderly population, a growing demand for point-of-care testing, a rising need for lateral flow assay kits for home use, and increasing disposable income levels in developing nations. The global lateral flow assay market is anticipated to be driven by additional factors like technical development and rising product usage. The demand for point-of-care testing in-home care environments that can provide findings in real-time (5-15 minutes) and is user-friendly is rising due to the increased prevalence of infectious and lifestyle diseases.

Functional advancements in lateral flow studies in terms of sensitivity, selectivity, and quantitative developments are being brought about by technological development. The intensity of a sample’s test line is frequently evaluated using manufacturers’ test readers. The appeal of portable lateral flow assay readers has grown as a result of their increasing portability and downsizing. The use of various frequencies for sample illumination and various sample recognition systems, such as CMOS or CCD detecting technologies, are driving technological advancements in lateral flow assay testing tools.

Advertisement
Stake.com

Additionally, the development of advanced image processing methods tailored specifically for testing has improved sample analyte measurement. Because these tools are so easy to use, the Lateral Flow Assay Market is expected to expand. Commercial interest is growing in alternative non-optical techniques like capillary pumping of sample fluid to reduce variation in sample volume and magnetic immunoassay (MIA).

Restraints

The market environment for lateral flow assays may be hampered by the stringent regulatory standards set by healthcare organizations like the U.S. FDA and the complicated clearance procedures. Lateral flow assays, which are classified as Class II devices, need to go through the 510(k) premarket notice procedure before they can be sold to the general public. These devices must undergo time-consuming review processes and tedious paperwork due to the stringent laws that govern them. There is a good possibility that the manufacturer will face significant penalties if these laws are broken or ignored.

Opportunities

The government has improved testing procedures to remain ahead of illness as a result of the rising frequency of infectious diseases. When a viral epidemic first starts, the government takes three preventive steps: testing, contact tracing, and isolation of positive cases. Before the vaccine is created and given to every person, these procedures are essential. The market will benefit greatly from the expanding government support for the development of highly accurate lateral flow tests through financing and supportive policies. Studies and studies being done to evaluate artificial intelligence’s effectiveness to increase the precision and accuracy of test results have produced encouraging results. As a result, the market will expand faster thanks to technical progress and product innovations driven by both public and private actors.

Advertisement
Stake.com

Challenge

Only point-of-care initial screening is suitable for lateral flow assay assays. They also have a number of disadvantages, including inaccurate sample volume, which affects the precision of the result, restricting the total volume of the test and giving a sensitivity limit, and analysis times that rely on the type of sample. Additionally, strict oversight and inconsistent test results are likely to restrain the global market for lateral flow assays.

Recent developments

  • In January 2021, the global American company Abbott, which manufactures medical equipment and provides healthcare services, revealed that it had obtained CE certification for two additional applications of its Panbio COVID-19 Ag Rapid Test Device for the identification of the SARS-CoV-2 virus. (Asymptomatic testing and self-swabbing). A PanBio COVID-19 immunochromatographic test for the quick detection of the Sars-CoV-2 virus was introduced by the firm in 2020.
  • Thermo Fisher Scientific, an American provider of scientific equipment, reagents and supplies, and software services, declared the inauguration of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri, for the month of September 2020. The building is next to the company’s biologics manufacturing plant, and with a $50 million extension, Thermo Fisher’s bioproduction and pharma services companies will combine their skills to expedite innovation, improve efficiency, and double production capacity.

Market Segmentation

By Product

  • Kits & Reagents
  • Lateral Flow Readers
    • Lateral Flow Readers
    • Benchtop Readers
    • Digital Readers

By Application

  • Clinical Testing
    • Infectious Disease Testing
      • COVID-19
      • Mosquito Borne Disease Testing
      • Influenza Testing
      • Sexually Transmitted Infection Testing
        • STI Testing
        • HIV Testing
        • HPV Testing
        • Chlamydia Testing
        • Gonorrhea Testing
        • Syphilis Testing
        • Other STI Testing
          • Hepatitis
          • Tuberculosis
          • Other Infectious Diseases
        • Cardiac Marker Testing
          • Troponin I and T Testing
          • CK-MB Testing
          • BNP and NT-Probnp Testing
          • Myoglobin Testing
          • D-Dimer Testing
          • Other Cardiac Marker Tests
        • Pregnancy & Fertility Testing
          • Pregnancy Testing
          • Fertility Testing
        • Cholesterol Testing/Lipid Profile
        • Drugs of Abuse Testing
        • Other Clinical Tests
      • Veterinary Diagnostics
      • Food Safety & Environment Testing
      • Drug Development & Quality Testing

By Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

By Test Type

  • Lateral Flow Immunoassay
  • Nucleic Acid Lateral Flow Assay

By End-User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical & Biotechnology Companies
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2883

You can place an order or ask any questions, please feel free to contact at [email protected] | +1 9197 992 333

Advertisement
Stake.com

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

Advertisement
Stake.com

https://twitter.com/Precedence_R

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Lucinity’s AI Innovation Recognized at Microsoft’s Prestigious Global Partner Awards 2024

Published

on

lucinity’s-ai-innovation-recognized-at-microsoft’s-prestigious-global-partner-awards-2024

REYKJAVIK, Iceland, June 28, 2024 /PRNewswire/ — Lucinity has been recognized as a finalist in the AI Innovation category at the prestigious Microsoft Global Partner Awards 2024, recognizing its breakthrough AI solution and contribution to financial security through its collaboration with Microsoft. 

Lucinity beat more than 4,700 companies to be named a finalist at the annual Microsoft Global Partner Awards, which highlights Lucinity’s achievements as a Microsoft partner in optimizing business processes, improving customer experiences, and opening new pathways for digital transformation.
This achievement comes in addition to winning two prestigious awards at Microsoft Partner Awards 2024 last month, including Partner of the Year – Iceland, and the Sustainability and Social Impact award.
The accolade recognizes Lucinity’s significant advancements in AI for financial crime operations, particularly through their AI-powered copilot, Luci. This innovative solution utilizes Microsoft Azure OpenAI technology to integrate advanced generative AI into financial crime investigations and regulatory compliance, optimizing processes and saving significant time and resources for financial institutions.
The Lucinity platform streamlines compliance, provides instant insights, and reduces typical investigation times from three hours to just 30 minutes. The technology can also save financial institutions an estimated $100 million in productivity savings, as well as savings in training and recruitment.
Microsoft comments on Lucinity’s award recognition, saying “Financial crime profoundly impacts our global community, with far-reaching economic, security, and social implications. It can harm a country’s reputation and increase exposure to criminal activities, emphasizing the critical need for robust anti-money laundering initiatives and persistent vigilance. Lucinity, with their innovative AI solutions, has really tried to combat this huge global challenge. They use ‘Human AI’ to enhance financial crime prevention, combining AI with human expertise for efficient, user-friendly solutions. Additionally, Lucinity has developed a tool called Luci, an AI-powered copilot that helps transform financial crime prevention from a process that took hours to one that takes minutes.”
“Being recognized as a finalist at the Microsoft Global Partner Awards is  validation of our impactful collaboration with Microsoft in financial crime operations. Our partnership has been pivotal for our innovations, enabling us to use Azure OpenAI to bring tools like Luci to life and deliver impactful results for our clients,” says Guðmundur Kristjánsson, Founder & CEO of Lucinity.
Contact:Name: Celina PabloEmail: [email protected]: +354 792 4321
Logo: https://mma.prnewswire.com/media/2208676/4669079/Lucinity_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lucinitys-ai-innovation-recognized-at-microsofts-prestigious-global-partner-awards-2024-302186091.html

Continue Reading

Artificial Intelligence

Asia Pacific View: Foreigners Looking for the Most Practical Smart Technology at the 2024 World Intelligence Expo

Published

on

asia-pacific-view:-foreigners-looking-for-the-most-practical-smart-technology-at-the-2024-world-intelligence-expo

BEIJING, June 28, 2024 /PRNewswire/ — Bionic robots that speak both Chinese and English can have the same skin and nails as humans? A flying car powered solely by wind can have a maximum payload of 160 kg? A smart wheelchair can control its operation with just the “mind”? Kevin and Daria, two foreign bloggers, have experienced during the World Intelligence Expo held in Tianjin how the artificial intelligence can empower people’s future lives in industries such as technology, trade, logistics and cultural tourism.

 
With the theme of “Intelligent Travel Empowering Future”, the Expo integrates exhibitions, experiences and events, attracting more than 550 exhibitors and institutions from all over the world, including more than 70 well-known enterprises such as Huawei, Alibaba, Baidu and Danfoss, and 57 universities and research institutions such as Peking University, Tsinghua University, Nankai University and Tianjin University. The Expo set up 10 major themes such as artificial intelligence, intelligent networked vehicles, intelligent manufacturing and robots, covering the frontier hot spots of the intelligent industry. A number of cutting-edge new technologies, new products, and new experiences from all over the world were showcased centrally, reminding people that technology will completely change the lifestyles in the future.
At the exhibition site, various intelligent robot products such as humanoid robots, bionic robots, and intelligent robot dogs interact with the audience on the spot. They are no longer fantasies in science fiction or movies, but play an important role in monitoring, rescue, cultural tourism and other fields. In the low-altitude economic exhibition area, a number of drones, flying vehicles, and aerospace technology companies collectively display advanced technology products. A low-altitude aircraft shaped like a helicopter brought by the German company Tensor can independently complete cargo transportation, takeoff and landing according to pre-set routes according to the instructions. Robotic arms incorporating technologies such as 5G, IoT, edge computing, rocker robotics, and artificial intelligence can shoot high-frame-rate video and support autofocus, achieving effects that cannot be achieved in traditional shooting modes. Viewers can also have more novel experiences with the help of smart technology.
The Expo also hosted three major events such as the Asia-Pacific Robotics World Cup Tianjin International Invitational, the World Intelligent Driving Challenge, and the International Intelligent Sports Conference. A number of technological achievements and innovative applications were demonstrated in the competitions. For exhibiting companies, this Expo is also an opportunity to further promote the transformation of enterprises to information technology and digitalization, and will also bring huge business opportunities.
Contact: Guo RanPhone: 008610-68332663Email: [email protected] 
Video: https://www.youtube.com/watch?v=VjjzurfN_r0 Logo:  https://mma.prnewswire.com/media/2451195/logo_Asia_Pacific_View_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/asia-pacific-view-foreigners-looking-for-the-most-practical-smart-technology-at-the-2024-world-intelligence-expo-302186046.html

Continue Reading

Artificial Intelligence

Tech Companies Leading the Charge in the Transformative AI Era

Published

on

tech-companies-leading-the-charge-in-the-transformative-ai-era

USA News Group Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 28, 2024 /PRNewswire/ — USA News Group – The world is changing rapidly thanks to artificial intelligence (AI), with what’s being called the Transformative AI era which comes with great benefits and also potential dangers. The economic impacts are global, with a new report from The Bank for International Settlements (BIS) urging central banks to adapt rapidly to AI advances. Now it’s become apparent how important it is for companies to understand how to harness the full potential of GenAI to secure strategic revenue growth in the coming years. The surge of AI’s usefulness is accelerating innovation in R&D, while behind the scenes tech companies are advancing the infrastructure required to keep this revolution going, including new developments from Avant Technologies Inc. (OTCQB: AVAI), Accenture plc (NYSE: ACN), Cloudflare, Inc. (NYSE: NET), Alphabet Inc. (NASDAQ: GOOG, GOOGL), and Amazon.com, Inc. (NASDAQ: AMZN).

Known for pioneering advancements in AI, Avant Technologies Inc. (OTCQB: AVAI) has persistently refined and expanded its premier offering, Avant AI™. This sophisticated AI platform, celebrated for its machine learning and deep learning capabilities, is the culmination of Avant’s efforts to deliver unprecedented and cost-effective compute infrastructure that unlocks the full potential of AI and ushers in a new era of technological advancement. 
“There is a real unmet need as rapid growth across the entirety of the AI and big data industries is outpacing the necessary infrastructure for an industry that demands exponential power and capacity while remaining cost effective,” said Avant’s CEO William Hisey in a recent address of progress on AI supercomputer-driven data centers. “Avant’s ‘edge-native’ approach doesn’t rely on cloud-based services so we can offer AI and big data companies many advantages over the more familiar ‘cloud-native’ approach, including, reduced latency, improved security and privacy, increased scalability, and reduced costs.”
In a recent strategic development, Avant entered into a Binding Letter of Intent (BLOI) with Flow Wave, LLC (FW), a prominent Florida-based firm specializing in immersible computer server technology. This agreement allows Avant to acquire up to 50 cutting-edge immersible computer servers from FW, in a transaction valued at $50 million.
“By integrating proprietary machine learning algorithms with open-source innovations into these servers, Avant is developing a highly intelligent system designed to optimize resource allocation, enhance performance, and drive unprecedented levels of efficiency and automation,” said Hisey.  “This marks the beginning of a new era for Avant Technologies, positioning us at the forefront of the supercomputer-driven data center industry and setting new standards for managing and storing AI applications.”
Flow Wave Immersible AI Supercomputer Servers are engineered for demanding AI and machine learning applications, delivering powerful processing capabilities that accelerate data analysis. Their cutting-edge cooling system is both energy-efficient and cost-effective, reducing environmental impact. These servers’ compact design facilitates easy installation in space-constrained data centers, and their robust construction ensures longevity and lower maintenance requirements.
In response to digital era challenges, Avant intends to acquire up to 50 of these high-performance servers. Their superior cooling technology boosts performance while conserving energy, aligning with Avant’s goal of providing top-tier AI infrastructure and maximizing efficiency. Additional details about the acquisition will be shared once the final agreement is secured.
In Q3 2024, Accenture plc (NYSE: ACN) brought in over $900 million in new Generative AI bookings, for a total of $2 billion fiscal year-to-date. Despite missing its overall earnings targets, the market responded by sending its shares upward.
“We achieved strong new bookings of over $21 billion, up 22% over last year, and continued to accelerate our strategy to be the reinvention partner of choice, with another 23 clients with quarterly bookings of over $100 million, bringing the total of such bookings to 92 year-to-date,” said Julie Sweet, Chair and CEO of Accenture. “We also achieved two significant milestones this quarter — with $2 billion in Generative AI sales year-to-date and $500 million in revenue year-to-date — which demonstrate our early lead in this critical technology.”
Back in May, Accenture took steps to help its clients to scale their Generative AI responsibly.
“Clients are eager to embrace the potential of generative AI, and we are ready to help them build responsible AI into every use,” said Sweet. “We do this for ourselves, and we can use that example to help our clients find success faster. Our focus is to enable our clients to innovate AI safely and be ready to seize the opportunities that AI will bring in the decades ahead.”
Recently, the cloud-based security solution provider Cloudflare, Inc. (NYSE: NET) unveiled the general availability of its AI Gateway platform. Marketed as a comprehensive interface for managing and scaling generative AI workloads, the platform has transitioned from its beta phase, which started in September 2023, to full client use after successfully handling over 500 million requests.
This launch coincides with Cloudflare’s announcement of a partnership with Hugging Face, a leading platform for AI developers. The collaboration offers a one-click global deployment for AI applications via the Workers AI platform, now also generally available. As the first serverless inference partner integrated on the Hugging Face Hub, this allows developers to deploy AI models quickly, easily, and cost-effectively on a global scale, without the need for managing infrastructure or paying for unused compute capacity.
“Workers AI is one of the most affordable and accessible solutions to run inference,” said Matthew Prince, CEO and co-founder, Cloudflare. “With Hugging Face and Cloudflare both deeply aligned in our efforts to democratize AI in a simple, affordable way, we’re giving developers the freedom and agility to choose a model and scale their AI apps from zero to global in an instant.”
In the education space, Alphabet Inc. (NASDAQ: GOOG, GOOGL) through Google, is bringing new AI tools to Google Workspace for teen students using their school accounts to help them learn responsibly and confidently in an AI-first future, and empowering educators with new tools to help create great learning experiences.
“In the coming months, we’re making Gemini available to teen students that meet our minimum age requirements while using their Google Workspace for Education accounts in English in over 100 countries around the world, free of charge for all education institutions,” said Google in a blog post. “To ensure schools are always in control, Gemini will be off by default for teens until admins choose to turn it on as an Additional Service in the Admin console.”
Google has also developed a number of resources and trainings to help students, parents and educators use generative AI tools responsibly and effectively, including a video on how teens can responsibly use AI while learning.
After recently hitting a $2-trillion valuation, Amazon.com, Inc. (NASDAQ: AMZN) continues to be a big player in the AI space. Now it’s reportedly working on its own AI chatbot that some say might be smarter than ChatGPT, named Metis, which will generate answers by grabbing info from the internet.
Metis is driven by an internal Amazon AI model known as Olympus, drawing inspiration from Greek mythology. According to sources, Olympus is a more advanced version of Amazon’s publicly available Titan model.
Amazon’s CEO Andy Jassy has noted that nearly every division within the company is engaged in some form of AI project. As a pioneer in cloud computing, Amazon has been developing machine learning, a subset of AI, for many years. Jassy recently announced that Amazon’s AI initiatives are projected to generate over $1 billion in annual revenue, with expectations of driving “tens of billions of dollars” in sales in the coming years.
However, Amazon has lagged in the realm of consumer AI assistants. An internal document from last year highlighted that Amazon “does not have a publicly or internally available product that looks and works exactly like ChatGPT.”
According to a source reported by Business Insider, the tentative launch date for Metis is September, right around the time when Amazon is set to host a big Alexa event, although the timeline could still change.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
CONTACT:
USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/tech-companies-leading-the-charge-in-the-transformative-ai-era-302185931.html

Continue Reading

Trending